Fangping Liu
6PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 02, 2024
Dihydromyricetin Suppresses Lipopolysaccharide-Induced Intestinal Injury Through Reducing Reactive Oxygen Species Generation and NOD-Like Receptor Pyrin Domain Containing 3 Inflammasome Activation.Yicong Chang, Xinru Jiang, Zhenghua Ji
|Jan 25, 2022
Dihydromyricetin alleviates Escherichia coli lipopolysaccharide-induced hepatic injury in chickens by inhibiting the NLRP3 inflammasome.Chenxi Shi, Jiaqi Wang, Ruichen Zhang
|May 07, 2021
Drug-induced liver injury: Oltipraz and C2-ceramide intervene HNF-1α/GSTA1 expression via JNK signaling pathway.Yuanyuan Zhang, Bingke Ma, Shuangshuang Hao
|Feb 07, 2021
Hematologic and biochemical reference intervals for 1-month-old specific-pathogen-free Landrace pigs.Changwen Li, Feng Wang, Rui Li
|May 26, 2020
Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway.Yicong Chang, Liang Yuan, Jiarui Liu
|Aug 07, 2019
Acetaminophen-induced hepatocyte injury: C2-ceramide and oltipraz intervention, hepatocyte nuclear factor 1 and glutathione S-transferase A1 changes.Yicong Chang, Feng Wang, Yang Yang
Pageof 1
